Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients
Open Access
- 21 April 2024
- journal article
- research article
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 46, 100785
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
- Sjöbergstiftelsen
- Cancerfonden
This publication has 31 references indexed in Scilit:
- Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell LymphomaJournal of Clinical Oncology, 2014
- 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trialThe Lancet Oncology, 2014
- Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal InvolvementJournal of Clinical Oncology, 2013
- Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret HospitalLeukemia & Lymphoma, 2012
- Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trialRadiotherapy and Oncology, 2011
- Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014Journal of Clinical Oncology, 2008
- Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin LymphomaJNCI: Journal of the National Cancer Institute, 2005
- Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classificationAnnals of Oncology, 2004
- Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin DiseaseJAMA, 2003
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1998